Tuberculosis-associated mortality in Shanghai, China: A longitudinal study;Mortalité due à la tuberculose à Shanghai, en Chine: une étude longitudinal;La mortalidad por tuberculosis en Shangh ái, China: un estudio longitudinal

Bulletin of the World Health Organization

Volumn 93, Issue 12, 2015, Pages 826-833

  Wang, Weibing ^a   Zhao, Qi ^a   Yuan, Zhengan ^b   Zheng, Yihui ^c   Zhang, Yixing ^d   Lu, Liping ^e   Hou, Yun ^f   Zhang, Yue ^a   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b Disease Control and Prevention Center of Changning Area   (China)

^c Jiading District Center for Disease Control and Prevention   (China)

^d Shanghai Pudong Center for Disease Control and Prevention   (China)

^e Baoshan District Center for Disease Control and Prevention   (China)

^f Center for Disease Control and Prevention of Yangpu District   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

COHORT ANALYSIS; MORTALITY RISK; PARTICIPATORY APPROACH; REGRESSION ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; CHINA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH CARE FACILITY; HUMAN; INFANT; LONGITUDINAL STUDY; LUNG CANCER; LUNG CAVITATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; RISK FACTOR; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; STANDARDIZED MORTALITY RATIO; THORAX RADIOGRAPHY; TUBERCULOSIS; VERY ELDERLY; AGE DISTRIBUTION; EPIDEMIOLOGY; INTERVIEW; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; SEX RATIO; SPUTUM; YOUNG ADULT;

CHINA; SHANGHAI;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; COMORBIDITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; SPUTUM; TUBERCULOSIS; YOUNG ADULT;

EID: 84948987221     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.15.154161     Document Type: Article

References (36)

1. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010 Feb;10(2):103–11. doi: http://dx.doi.org/10.1016/S1473-3099(09)70330-5 PMID: 20113979
2. Global tuberculosis report 2013. Geneva: Global Tuberculosis Programme, World Health Organization; 2013. pp. 6–27. Available from: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf [cited 2015 Sep 11].
3. Wang L, Zhang H, Ruan Y, Chin DP, Xia Y, Cheng S, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014 Jun 14;383(9934):2057–64. doi: http://dx.doi.org/10.1016/S0140-6736(13)62639-2 PMID: 24650955
4. Cullinan P, Meredith SK. Deaths in adults with notified pulmonary tuberculosis 1983–5. Thorax. 1991 May;46(5):347–50. doi: http://dx.doi.org/10.1136/thx.46.5.347 PMID: 2068691
5. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012 Jun 7;366(23):2161–70. doi: http://dx.doi.org/10.1056/NEJMoa1108789 PMID: 22670902
6. Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, et al. Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis. 2009;9(1):95. doi: http://dx.doi.org/10.1186/1471-2334-9-95 PMID: 19531267
7. The office of the fifth national TB epidemiological survey. Report on nationwide random survey for the epidemiology of tuberculosis in 2010. Journal of Chinese Anti-Tuberculosis Association. 2012;34(8):485–508.
8. International statistical classification of diseases and related health problems. 10th revision, edition 2010. Geneva: World Health Organization; 2010. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf?ua=1 [cited 2015 Sep 25].
9. Xu J, Tang W, Cheng S, Mahapatra T, Zhou L, Lai Y, et al. Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS ONE. 2014;9(2):e89723. doi: http://dx.doi.org/10.1371/journal.pone.0089723 PMID: 24586987
10. Li X, Deng Y, Lin L, Gao D, Graviss EA, Ma X. HIV infection among TB and non-TB patients in China, 2009–2012. J Infect. 2014 Apr;68(4):399–400. doi: http://dx.doi.org/10.1016/j.jinf.2013.12.015 PMID: 24412569
11. Straetemans M, Glaziou P, Bierrenbach AL, Sismanidis C, van der Werf MJ. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS ONE. 2011;6(6):e20755. doi: http://dx.doi.org/10.1371/journal.pone.0020755 PMID: 21738585
12. An expanded DOTS framework for effective tuberculosis control. Int J Tuberc Lung Dis. 2002 May;6(5):378–88. PMID: 12019913
13. Lin CH, Lin CJ, Kuo YW, Wang JY, Hsu CL, Chen JM, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis. 2014;14(1):5. doi: http://dx.doi.org/10.1186/1471-2334-14-5 PMID: 24387757
14. Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003 Aug;7(8):742–50. PMID: 12921150
15. Wang WB, Zhao Q, Yuan ZA, Jiang WL, Liu ML, Xu B. Deaths of tuberculosis patients in urban China: a retrospective cohort study. Int J Tuberc Lung Dis. 2013 Apr;17(4):493–8. doi: http://dx.doi.org/10.5588/ijtld.12.0400 PMID: 23433006
16. China health statistical yearbook 2013. Laiyun: China Statistics Press; 2013. Available from: http://www.stats.gov.cn/tjsj/ndsj/2013/indexeh.htm [cited 2015 Sep 25].
17. Kolappan C, Subramani R, Karunakaran K, Narayanan PR. Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ. 2006 Jul;84(7):555–60. doi: http://dx.doi.org/10.1183/09031936.98.11040816 PMID: 9623682
18. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N. Mortality among tuberculosis patients in The Netherlands in the period 1993–1995. Eur Respir J. 1998 Apr;11(4):816–20. doi: http://dx.doi.org/10.2471/BLT.05.022087 PMID: 16878229
19. Datiko DG, Lindtjørn B. Mortality in successfully treated tuberculosis patients in southern Ethiopia: retrospective follow-up study. Int J Tuberc Lung Dis. 2010 Jul;14(7):866–71. PMID: 20550770
20. Mi F, Jiang G, Du J, Li L, Yue W, Harries AD, et al. Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China. Glob Health Action. 2014;7(0):24022. doi: http://dx.doi.org/10.3402/gha.v7.24022 PMID: 24845213
21. Liew SM, Khoo EM, Ho BK, Lee YK, Mimi O, Fazlina MY, et al. Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry. Int J Tuberc Lung Dis. 2015 Jul;19(7):764–71. doi: http://dx.doi.org/10.5588/ijtld.14.0767 PMID: 26056099
22. Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008 Jun;31(6):1256–60. doi: http://dx.doi.org/10.1183/09031936.00131107 PMID: 18515556
23. Anuwatnonthakate A, Limsomboon P, Nateniyom S, Wattanaamornkiat W, Komsakorn S, Moolphate S, et al. Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS ONE. 2008;3(8):e3089. doi: http://dx.doi.org/10.1371/journal.pone.0003089 PMID: 18769479
24. Bloss E, Chan PC, Cheng NW, Wang KF, Yang SL, Cegielski P. Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan. Int J Tuberc Lung Dis. 2012 Apr;16(4):462–7. doi: http://dx.doi.org/10.5588/ijtld.11.0121 PMID: 22640512
25. Khogali M, Zachariah R, Reid T, Alipon SC, Zimble S, Mahama G, et al. Self-administered treatment for tuberculosis among pastoralists in rural Ethiopia: how well does it work? Int Health. 2014 Jun;6(2):112–7. doi: http://dx.doi.org/10.1093/inthealth/ihu008 PMID: 24639343
26. Das M, Isaakidis P, Armstrong E, Gundipudi NR, Babu RB, Qureshi IA, et al. Directly-observed and self-administered tuberculosis treatment in a chronic, low-intensity conflict setting in India. PLoS ONE. 2014;9(3):e92131. doi: http://dx.doi.org/10.1371/journal.pone.0092131 PMID: 24651176
27. van den Boogaard J, Lyimo R, Irongo CF, Boeree MJ, Schaalma H, Aarnoutse RE, et al. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania’s Kilimanjaro region. Int J Tuberc Lung Dis. 2009 Dec;13(12):1524–9. PMID: 19919771
28. Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J, Sørensen HT. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis. 2002 May;6(5):389–95. PMID: 12019914
29. Newell JN, Baral SC, Pande SB, Bam DS, Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet. 2006 Mar 18;367(9514):903–9. doi: http://dx.doi.org/10.1016/S0140-6736(06)68380-3 PMID: 16546538
30. Lui G, Wong RY, Li F, Lee MK, Lai RW, Li TC, et al. High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting. PLoS ONE. 2014;9(3):e92077. doi: http://dx.doi.org/10.1371/journal.pone.0092077 PMID: 24642794
31. Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, Lode H. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J. 2006 Jun;27(6):1223–8. doi: http://dx.doi.org/10.1183/09031936.06.00088105 PMID: 16481385
32. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, et al. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int J Tuberc Lung Dis. 2006 Aug;10(8):857–63. PMID: 16898369
33. Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009 Jan;13(1):105–11. PMID: 19105887
34. Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011 Jul;15(7):886–91. doi: http://dx.doi.org/10.5588/ijtld.10.0526 PMID: 21477424
35. Wei X, Walley JD, Liang X, Liu F, Zhang X, Li R. Adapting a generic tuberculosis control operational guideline and scaling it up in China: a qualitative case study. BMC Public Health. 2008;8(1):260. doi: http://dx.doi.org/10.1186/1471-2458-8-260 PMID: 18662410
36. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ. 2002;80(3):217–27. PMID: 11984608